EAU 2018

EAU 2018: Marker-Driven Use of NAC In (T2) Urothelial Cancer in an Otherwise Healthy Patient?

Copenhagen, Denmark (UroToday.com) This is one of a series of case-based debates. Each is set up as follows: 2 min case-presentation, 5-min discussant presentation (two sides of the debate, discussion), summary 2 minutes. This was an excellent series arranged by HB Grossman, P. Black, and J. Bellmunt.

EAU 2018: What Patient Factors Predict PSA Testing Among Men Aged 50 And Above?

Copenhagen, Denmark (UroToday.com) PSA screening for early detection of prostate cancer (PC) is a controversial issue, especially since the United States Preventive Services Task Force (USPSTF) recommendation against screening (2012). The authors analyzed which patient factors predicted PSA screening receipt and physician-patient shared decision making.

EAU 2018: Complications of Hormonal Treatment in Prostate Cancer

Copenhagen, Denmark (UroToday.com)  Dr. Sommer gave an overview of the complications associated with the treatment for advanced prostate cancer. The first topic discussed was the acute side effects of androgen deprivation therapy (ADT). These include decreased libido, erectile dysfunction, hot flushes, and fatigue. The chronic side effects include anemia, osteoporosis/fractures, obesity, sarcopenia, lipid alterations, insulin resistance and diabetes. ADT is also associated with other problems, including cardiovascular disease, thromboembolism, colorectal cancer, depression, dementia, and renal failure. 

EAU 2018: Renal Cancer: Partial Nephrectomy, Immediate and Late Complications – Open Technique

Copenhagen, Denmark (UroToday.com) Dr. Alessandro Volpe presented an expansive overview of the immediate and late complications following open partial nephrectomy (OPN). He began with a historical overview of OPN, the first of which was performed in 1889. Enthusiasm, however, was low for this procedure because of the perceived high risk of complications. After decades of improved knowledge and technique gained through improvements in stone surgery and trauma surgery, the groundwork for safe OPN for oncologic surgery was laid. Pioneers such as Andrew Novick then pushed the field forward, shifting the approach of managing patients with small renal masses (SRMs). 

EAU 2018: Renal Cancer: Partial Nephrectomy, Immediate and Late Complications - Laparoscopic

Copenhagen, Denmark (UroToday.com) Laparoscopic partial nephrectomy (LPN) is a difficult and technically challenging procedure. Dr. Skolarikos presented on experiences with LPN over time. Although it is safe and feasible in select hands, complication rates compared to open PN remain somewhat high (up to 1/3 of patients will develop some complication). That said, the reported rates of complications are not dramatically different than published series of robotic partial nephrectomy.

EAU 2018: Impact of antiplatelet and anticoagulation therapy for patients undergoing HOLEP in terms of hospitalization length and complications rate: A prospective study

Copenhagen, Denmark (UroToday.com) Dr. B. Branchu, a clinical urologist from CHU de Reims, Dept. of Urology, Reims, France, presented a comparison between hospitalization times and the complications of benign prostatic hyperplasia undergoing HoLEP as a result of anticoagulation or antiplatelet therapy.

EAU 2018: One-Lobe Enucleation HoLEP Could Be Safely Performed Especially for Large Prostate

Copenhagen, Denmark (UroToday.com) Dr. N. Terada, a clinical urologist from Miyazaki University, Dept. of Urology, Miyazaki, Japan, presented an evaluation of the efficacy of Holmium-laser enucleation of prostate (HoLEP) for especially large prostates by comparing the one-lobe approach to the standard two-lobe procedure.